BioNote, Inc. (KRX:377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,280.00
-20.00 (-0.38%)
At close: Jul 21, 2025, 3:30 PM KST
29.10%
Market Cap535.19B
Revenue (ttm)105.92B
Net Income (ttm)42.38B
Shares Out101.36M
EPS (ttm)416.22
PE Ratio12.69
Forward PEn/a
Dividend200.00 (3.77%)
Ex-Dividend DateMar 28, 2025
Volume42,783
Average Volume69,970
Open5,330.00
Previous Close5,300.00
Day's Range5,220.00 - 5,330.00
52-Week Range3,990.00 - 6,400.00
Beta1.05
RSI56.29
Earnings DateAug 14, 2025

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.